ROZLYTREK gél 200 mg 90 pce

7680672800028 CH-67280 L01EX14 07.16.1.

Reimbursement limitations:

ROZLYTREK.01

Tumeurs solides
Le traitement nécessite une garantie de prise en charge des frais par l’assureur-maladie …

ROZLYTREK gél 200 mg 90 pce
ROZLYTREK gél 200 mg 90 pce
1 / 2
google

Details

Product number
6728002
CPT
-
Packaging group
90
Unit
Kapsel(n)
Composition
entrectinibum 200 mg, lactosum 130 mg, cellulosum microcristallinum, acidum tartaricum, hypromellosum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, Kapselhülle: hypromellosum, E 171, E 110 0.5543 mg, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, E 132, pro capsula.

Articles (1)

Rozlytrek 200 mg, Hartkapseln
Kapseln
90
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
25/09/2025
Patient information leaflet
Français
25/09/2025
Patient information leaflet
Italien
25/09/2025
Professional SmPC
Allemand
25/09/2025
Professional SmPC
Français
25/09/2025
Professional SmPC
Italien
25/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
130.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
0.5543 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK

Reimbursement information

Public price
CHF 5342.05
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2022

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
67280
Drug name
Rozlytrek, Hartkapseln
Galenic form
KAHA
ATC Code
L01EX14
Authorization status
Z
Dispensation category
A
First authorization
05/11/2020
Authorization expiration date
20/07/2028
IT number
07.16.1.
Domain
Human medicine
Field of application
Solide Tumoren, nicht-kleinzelliges Bronchialkarzinom (NSCLC)

Packaging details

Description (FR)
ROZLYTREK gél 200 mg 90 pce
Description (DE)
ROZLYTREK Kaps 200 mg 90 Stk
Market launch
05/11/2020
Narcotic (BTM)
No

Other packaging sizes

ROZLYTREK gél 100 mg 30 pce
30 KAP
View